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Although imbalances in gut microbiota composition,
or ‘‘dysbiosis,’’ are associated with many diseases,
the effects of gut dysbiosis on host systemic physi-
ology are less well characterized. We report that
gut dysbiosis induced by antibiotic (Abx) treatment
promotes allergic airway inflammation by shifting
macrophage polarization in the lung toward the alter-
natively activated M2 phenotype. Adoptive transfer
of alveolar macrophages derived from Abx-treated
micewas sufficient to increase allergic airway inflam-
mation. Abx treatment resulted in the overgrowth of a
commensal fungal Candida species in the gut and
increased plasma concentrations of prostaglandin
E2 (PGE2), which induced M2 macrophage polariza-
tion in the lung. Suppression of PGE2 synthesis by
the cyclooxygenase inhibitors aspirin and celecoxib
suppressed M2 macrophage polarization and
decreased allergic airway inflammatory cell infiltra-
tion in Abx-treated mice. Thus, Abx treatment can
cause overgrowth of particular fungal species in
the gut and promote M2 macrophage activation
at distant sites to influence systemic responses
including allergic inflammation.
INTRODUCTION
Imbalances in gut microbiota composition, described as ‘‘dys-
biosis,’’ are caused by many factors, including host genetics,
lifestyle, and exposure to microorganisms or various medical
procedures (Round and Mazmanian, 2009). Dysbiosis has
been associated not only with intestinal inflammation (Elinav
et al., 2011; Mazmanian et al., 2008) but also with many diseases
outside the gut, such as atopic dermatitis, allergy, obesity, and
diabetes (Arumugam et al., 2011; Henao-Mejia et al., 2012;
Penders et al., 2007; Vijay-Kumar et al., 2010). However, howCell Hothe gut dysbiosis influences host immunity outside the gastroin-
testinal tract is largely unknown.
Several examples of the systemic influence of the commensal
bacteria on peripheral immune responses have recently been
provided. Peptidoglycan from orally inoculated E. coli enhanced
killing of Streptococcus pneumoniae and Staphcylococcus
aureus by bone-marrow-derived neutrophils in a Nod1-
dependent manner (Clarke et al., 2010). Short-chain fatty acids
(SCFAs), which were produced by fermentable dietary fiber
induced by commensal bacteria, protect against the develop-
ment of inflammatory diseases including colitis, arthritis, and
allergy (Maslowski et al., 2009). However, the vast majority of
these studies on interplay between commensal microbiota and
systemic immune responses have focused on gut bacteria but
not other microbes such as fungi or viruses.
Although more than 99% of microbiota consists of bacteria,
fungi, most of which are Candida species, are also detectable
in gastrointestinal sections of about 70% of healthy human
adults (Cohen et al., 1969). Dysbiosis can result from a loss
of beneficial commensal bacteria and an overgrowth of fungi
(Giuliano et al., 1987; Samonis et al., 1990). Candida infection
can induce production of inflammatory mediators by host cells.
Candida also produces ligands for pattern recognition re-
ceptors (PRRs), including b-glucans, chitin, mannans, b-(1,2)-
linked oligomannosides, and fungal nucleic acids, which
stimulate innate immune responses. In addition, Candida pro-
duces proinflammatory substances such as alcohol (Santel-
mann and Howard, 2005) and prostaglandin (PGE2) (Noverr
et al., 2001). Several studies have suggested that gut fungi
can influence inflammatory disorders such as inflammatory
bowel disease (Iliev et al., 2012; Ott et al., 2008) or allergic
airway inflammation (Noverr et al., 2004). However, although
the study of the fungal microbiota is a rapidly emerging
field, the mechanisms by which gut dysbiosis-driven fungal
overgrowth in the gut affects host immune responses remain
poorly understood.
Here we provide the evidence that Candida overgrowth
promotes M2 macrophage polarization via PGE2, which plays
a critical role in the increased allergic airway inflammatory cell
infiltration.st & Microbe 15, 95–102, January 15, 2014 ª2014 Elsevier Inc. 95
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Figure 1. Antibiotic Treatment Exacerbates Allergic Airway Inflammation
(A–D) Antibiotic (clindamycin + cefoperazone) (Abx)-treated or untreated () mice were challenged intranasally with papain every 3 days a total of five times. One
day after the final challenge, mice were analyzed for morphology of BAL cells (Wright’s stain, original magnification 1,0003) (A), total and differentiated cell counts
in BAL (B), lung histology (HE or PAS stain) (scale bar, 100 mm) (C), and cytokine concentration in BAL fluids (D). Representative results in each group of A (n =
7 or 8) and C (n = 46) are shown. Error bars indicate SD (D) (n = 7). Results are representative of three independent experiments (B and D). *p < 0.05; **p < 0.01.
N.S., not significant. See also Figure S1.
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Gut Dysbiosis Promotes M2 Macrophage PolarizationRESULTS
Antibiotic Treatment Promotes Allergic Airway
Inflammation
Treatment with antibiotics induces profound changes in the
numbers and composition of gutmicrobiota (Round andMazma-
nian, 2009). To directly assess the impact of dysbiosis on host
immunity outside the gut, we induced allergic airway inflamma-
tion by intranasal inhalation of the protease allergen papain in
control mice and mice treated with the antibiotics clindamycin
and cefoperazone (Abx-treated mice). Mice pretreated with anti-
biotics and challenged with papain had significantly greater
numbers of total cells, eosinophils, and macrophages in the
airways than did control mice (Figures 1A and 1B). We also
observed similar results when mice were challenged with house
dust mite extract (Figures S1A and S1B available online). Papain-
challenged Abx-treated mice also exhibited greater goblet cell
hyperplasia and peribronchial inflammatory cell infiltration than
did control mice (Figure 1C). We also found that the production
of IL-5, IL-13, CCL11, and CCL24, which are critical molecules
for type 2 immune responses and eosinophil recruitment and in
the pathogenesis of asthma, were significantly higher in Abx-
treated mice than in control mice after papain inhalation
(Figure 1D). Together, these findings suggest that antibiotic
treatment promotes allergen-induced airway inflammatory cell
infiltration.
Antibiotic Treatment Induces M2 Macrophage
Polarization
We next examined whether the increase in papain-induced
airway inflammatory cell infiltration by antibiotics requires the
adaptive immune system. To address this question, we treated
Rag-1/mice, which were deficient in mature B and T lympho-96 Cell Host & Microbe 15, 95–102, January 15, 2014 ª2014 Elseviercytes due to disruption of their differentiations, with antibiotics
and then challenged them with papain. Papain-induced airway
inflammatory cell infiltration was also significantly increased in
antibiotic-treated Rag-1/ mice than in control mice, suggest-
ing that antibiotic treatment can affect host immune responses
in the absence of adaptive immunity (Figure S1C). Treatment
with clodronate liposomes (liposome-encapsulated dichloro-
methylene bisphosphonate, Cl2MBP), which deplete macro-
phages (Mfs) and, in some cases, granulocytes and dendritic
cells in vivo, decreased the total number of cells and the
numbers of eosinophils and Mfs in the BAL fluid after papain
inhalation in mice that were either left untreated or treated with
Abx and resulted in the comparable numbers of BAL fluid cells
between both groups (Figure S2A), suggesting that alveolar
Mfs (AMfs) are involved in Abx-induced allergic airway
inflammatory cell infiltration. Moreover, mice that received
AMfs from Abx-treated mice exhibited significantly greater
numbers of BAL fluid cells than those that received AMfs from
control mice (Figure 2A). These results suggest that Abx treat-
ment altered macrophage function in some way that promotes
inflammation in the lung.
Mfs acquire distinct functional phenotypes by undergoing
classical activation as M1 macrophages or alternative activation
as M2 macrophages in response to various environmental fac-
tors. We found that, compared with AMfs purified from control
mice, AMfs purified from Abx-treated mice exhibited signifi-
cantly increased expression of arg1, chi3l3, and retnla, which
are markers of alternatively activated M2 macrophages (Figures
2B and S2B). Intranasal treatment with serum amyloid P (SAP),
which attenuates M2 macrophage activation (Moreira et al.,
2010), inhibited M2 macrophage activation in the lung, but not
in the peripheral blood, and suppressed papain-induced airway
inflammation, as evidenced by significant decrease in the totalInc.
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Figure 2. Antibiotic Treatment Induces M2 Macrophage Polarization
(A) Mice were adoptively transferred i.n. with alveolar macrophages (AMfs) purified from untreated () or Abx-treated mice and challenged with papain and
analyzed for BAL cells, as described in Figure 1.
(B) AMfs purified from untreated () or Abx-treated (+) mice were subjected to real-time RT-PCR (n = 5).
(C) Abx-treated (+) or untreated () mice were administered i.n. with SAP (+) or PBS () every 3 days a total of five times. One day after the final SAP treatment,
mice were analyzed for expression of M2 macrophage marker genes in AMfs (n = 5).
(D) Mice were left untreated () or treated with Abx and were challenged with papain every 3 days a total of five times. The mice were also injected i.n. with serum
amyloid P (SAP) or PBS 1 day before each papain challenge every 3 days a total of five times. One day after the final challenge with papain, mice were analyzed for
BAL cells, as described in Figure 1.
(E) Mice were adoptively transferred i.n. with bone-marrow-derived cultured macrophages (M0), M1 macrophages, or M2 macrophages and then challenged
i.n. with papain and analyzed for BAL cells, as described in Figure 1. Results are representative of three independent experiments.
*p < 0.05; **p < 0.01; ***p < 0.001. N.S., not significant. Error bars, SD. See also Figure S2.
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Gut Dysbiosis Promotes M2 Macrophage Polarizationnumbers of cells in the BAL fluids of mice treated with both Abx
and SAP compared with those treated with Abx and PBS (Fig-
ures 2C, 2D, and S2C). Adoptive transfer of M2, but not M1,
macrophages generated by culture of bone-marrow-derived
macrophages (M0 macrophages) into the nasal cavity signifi-
cantly increased papain-induced airway inflammatory cell
infiltration compared with transfer of M0 macrophages (Fig-
ure 2E), consistent with previous observations that M2 macro-
phages increase allergic airway inflammatory cell infiltration
(Ford et al., 2012; Moreira et al., 2010). These results suggest
that alveolar M2 Mfs are involved in the increased papain-
induced allergic airway inflammation.
Antibiotic Treatment Facilitates Fungal Overgrowth in
the Gut, which Induces M2 Macrophage Polarization
Antibiotics disrupt healthy microbial communities, allowing the
overgrowth of fungi (Giuliano et al., 1987; Samonis et al.,
1990). Furthermore, previous reports demonstrated that admin-
istration of oral antibiotics followed by oral inoculation of
Candida facilitated fungal overgrowth in the gut and promoted
allergic inflammation (Noverr et al., 2004). Therefore, we next
examined the effect of antibiotic treatment on fungal colonization
of the intestine. Treatment with cefoperazone, ampicillin, or
streptomycin as well as combination with cefoperazone and
clindamycin, but not with clindamycin, or metronidazole, signifi-
cantly promoted fungal overgrowth in the gut (Figure 3A). We
therefore compared the effect of combination with cefoperazone
and clindamycin with that of metronidazole on the microbiota inCell Hothe feces to analyze how Abx (cefoperazone and clindamycin)
treatment induced fungal overgrowth. Quantitative RT-PCR
analyses demonstrated that treatment with clindamycin and
cefoperazone markedly decreased the copy numbers of several
species of microbiota, including Clostridium clusters IV and
XIVab, Lactobacillus genus and Bacteroides genus (Figure S3A).
In contrast, these species of microbiota were not affected by the
treatment withmetronidazole that did not induce the fungal over-
growth in the gut (Figure S3A), suggesting that these microbiota
might be involved in inhibition of fungal overgrowth in the gut.
However, we did not observe fungal overgrowth in the lung
and oral cavity of Abx-treated mice (Figures 3A and S3B). Inter-
estingly, the level of intestinal fungal overgrowth was correlated
with the papain-induced enhancement of inflammatory cell influx
into the BAL fluid (Figures 3B and 3C). We obtained a fungal
isolate from the feces of Abx-treated mice and identified it as
Candida parapsilosis (C. parapsilosis) by 16S rDNA sequencing
(data not shown). Histological analyses of intestinal tissue sec-
tions of mice treated with Abx showed that Candida infiltration
was common in the lamina propria of cecal tissues but was
uncommon in the small intestine or colon (Figures 3D, 3E, and
S3C). Notably, Abx-treated mice did not show obvious histolog-
ical signs of inflammation throughout the gastrointestinal tract
(Figure S3C).
We did not observe overgrowth of any fungal species,
including C. albicans, C. glabrata, and C. tropicalis, as well as
C. parapsilosis, in the intestines of mice of the same strain ob-
tained from a commercial supplier (Clea Japan, Tokyo) afterst & Microbe 15, 95–102, January 15, 2014 ª2014 Elsevier Inc. 97
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Figure 3. Antibiotic Treatment Facilitates Fungal Overgrowth in the Gut, which Induces M2 Macrophage Polarization
(A–C) Mice were left untreated or treated orally with Abx (CLM, clindamycin; CPZ, cefoperazone; ABPC, ampicillin; MNZ, metronidazole; STM, streptomycin) for
2 weeks and analyzed for fungal colonization in the feces (A). Mice were then challenged i.n. with papain and analyzed for BAL cells, as described in Figure 1 (B).
Correlation between fungal colonization and total cell number in BAL was analyzed (C).
(D and E) Cecum sections inmice untreated () or treatedwith Abx (clindamycin + cefoperazone) for 2 weekswere stainedwith PAS (D) or DAB (E), as described in
the Supplemental Information. Arrows indicate Candida in the lamina propria. Scale bar, 10 mm.
(F–H) Mice were left untreated or treated orally with either Abx (clindamycin + cefoperazone) or Abx plus 5-FC for 2 weeks and analyzed for fungal colonization in
the feces (F). AMfs were subjected to real-time RT-PCR (G) (n = 5). Mice were then challenged i.n. with papain and analyzed for BAL cell number, as described in
Figure 1 (H). Results are representative of three independent experiments. *p < 0.05; **p < 0.01. N.S., not significant. See also Figure S3.
Cell Host & Microbe
Gut Dysbiosis Promotes M2 Macrophage Polarizationtreatment with Abx, suggesting that fungal overgrowth induced
by antibiotics was dependent on the mouse colony. Neverthe-
less, inoculation of commercial mice from Clea Japan into the
gut with exogenous C. parapsilosis enhanced the allergic airway
inflammatory cell infiltration induced by papain (Figure S3D, data
not shown). Furthermore, oral treatment of the commercial mice
with human-isolated Candida species (C. albicans, C. glabrata,
or C. tropicalis) led to fungal overgrowth in the gut (Figure S3D)
and significantly exacerbated airway inflammation induced by98 Cell Host & Microbe 15, 95–102, January 15, 2014 ª2014 Elsevierpapain (Figure S3D). Administration of 5-FC, an antifungal
drug, significantly reduced the fecal counts of fungi in
Abx-treated mice (Figure 3F). Furthermore, 5-FC treatment sup-
pressed the upregulation of M2 macrophage markers expres-
sion in AMfs from Abx-treated mice (Figure 3G) and significantly
decreased the BAL fluid cells of Abx-treated mice in our mouse
colony (positive for C. parapsilosis), but not in Abx-treated com-
mercial mice (negative for C. parapsilosis) after challenge with
papain (Figures 3H and S3E). These results indicated thatInc.
Cell Host & Microbe
Gut Dysbiosis Promotes M2 Macrophage PolarizationAbx-induced fungal overgrowth exacerbated papain-induced
airway inflammation by shifting macrophage polarization toward
the M2 phenotype.
Increased PGE2 Levels Associated with Intestinal
Fungal Overgrowth Contribute to M2 Polarization and
Increase in Allergic Airway Inflammatory Cell Infiltration
Because commensal-derived signals can stimulate immune
cells systemically (Abt et al., 2012), we investigated whether
fungal overgrowth in the intestine would affect the function of
peripheral blood monocytes. In Abx-treated mice, peripheral
blood monocytes also exhibited increased expression of M2
markers, arg1, chi3l3, and retnla (Figure 4A). Moreover, culture
of naive AMfs in the presence of sera obtained from mice
after, but not before, Abx treatment upregulated expression
of M2 markers (Figure S4A). These results suggest that
fungal components act systemically to alter macrophage func-
tion by regulating the M2 phenotype in the lung. However, we
did not detect b-D-glucan and mannan, two major cell compo-
nents of Candida, in the sera of Abx-treated mice (data not
shown).
Several evidences demonstrated that many fungi secrete
prostaglandins de novo or via conversion of exogenous arachi-
donic acid (Noverr et al., 2001, 2002). In addition, Candida can
activate host cells to produce prostaglandins (Gagliardi et al.,
2010; Lee et al., 2009). Prostaglandins such as prostaglandin
E2 (PGE2) enhance allergic inflammation (Church et al., 2012),
suggesting a possibility that overgrowth of gut fungal microbiota
may alter immune responses via PGE2. In fact, we found that
C. parapsilosis converted exogenous arachidonic acid into pros-
taglandins (Figure 4B). Furthermore, PGE2 metabolite (PGEM)
levels were significantly greater in both the sera and BAL fluid
of Abx-treated mice than in control mice (Figures 4C and 4D),
whereas the levels of PGEM in the sera were decreased in
mice treated with both Abx and 5-FC (Figure 4C). Papain
inhalation further increased PGEM levels in the BAL fluid of
Abx-treated mice, which were significantly decreased by the
additional treatment with 5-FC (Figure 4D). Innoculation of
Abx-treated commercial mice with human-isolated Candida
species also increased plasma PGE2 levels (Figure S4B). These
results suggest that fungal overgrowth in the gut increases the
levels of systemic and local PGE2.
Ptges/ mice are deficient in microsomal prostaglandin E
synthase-1 (mPGES-1) responsible for elevation of host-derived
PGE2 in inflamed tissues (Boulet et al., 2004; Church et al.,
2012; Claveau et al., 2003). Since fungal overgrowth was not
observed in both Abx-treated Ptges+/+ and Ptges/ mice,
exogenous C. parapsilosis was orally inoculated to those
mice. As a result, fungal colonization in the gut was similarly
observed in both Abx-treated Ptges+/+ and Ptges/ mice (Fig-
ure S4C). Abx-treated WT mice showed significantly higher
levels of plasma PGEM than did control WT mice (Figures 4C
and 4E). Consistent with a previous report (Church et al.,
2012), the basal levels of the plasma PGEM were lower in
Ptges/ mice than in WT mice (Figure 4E). Importantly, how-
ever, Abx treatment also increased the PGEM levels in Ptges/
mice as well as in Ptges+/+ mice significantly higher than in
respective control mice, although the increment of PGEM by
the treatment with Abx was smaller in Ptges/ mice than inCell HoPtges+/+ mice (Figure 4E). Nonetheless, these results suggest
that the increased PGEM might not be derived from host cells.
Interestingly, treatment with aspirin, an inhibitor of cyclooxyge-
nase (Cox) that converts arachidonic acid into PGG2 and thus
inhibits PGE2 synthesis, decreased PGE2 levels in both Abx-
treated WT and Ptges/ mice (Figure 4E). Aspirin treatment
did not affect fungal overgrowth in both mice (Figure S4C).
Accordingly, aspirin also downregulated M2 macrophage
marker expression in AMfs from both Abx-treated Ptges+/+
and Ptges/ mice (Figures 4F and S4D). Furthermore, treat-
ment with aspirin or celecoxib, a selective Cox-2 inhibitor,
decreased papain-induced airway inflammatory cell infiltration
in both Abx-treated WT mice and Ptges/ mice (Figures 4G,
4H, and S4E). Collectively, these results suggest that inhibition
of PGE2 synthesis is sufficient to prevent increase in allergic
inflammatory cell infiltration in Abx-treated mice.
Intraperitoneal injection of PGE2 significantly enhanced ex-
pressions of M2 macrophage markers in AMfs (Figure 4I) and
increased papain-induced airway inflammatory cell infiltration
(Figure 4J). Finally, adoptive transfer of AMfs stimulated with
PGE2 in vitro into the nasal cavity of naive mice significantly
increased papain-induced airway inflammatory cell infiltration
compared with the transfer of untreated AMfs (Figure 4K).
Although papain-induced airway inflammatory cell infiltration
was suppressed by the treatment with 5-FC in Abx-treated
mice that transferred i.n. with untreated AMfs, Abx-treated
mice transferred with PGE2-stimulated AMfs showed enhanced
papain-induced allergic airway responses regardless of the
additional treatment with 5-FC (Figure S4F). Taken together,
these results suggest that PGE2 produced by gut fungi exacer-
bates eosinophil-mediated airway inflammation by altering the
AMf phenotype toward M2 in Abx-treated mice.
DISCUSSION
Previous reports showed that treatment with antibiotics pro-
motes overgrowth of fungi in the gut and T cell-dependent airway
inflammation by an undetermined mechanism (Noverr et al.,
2005). The present study demonstrates that gut fungi alter the
macrophage phenotype toward M2 via PGE2, which can modu-
latemacrophage responses, resulting in enhancement of allergic
airway inflammation. A recent report also demonstrated that
PGE2 promotes lung inflammation (Church et al., 2012). We pro-
vided evidence that the elevated PGE2 level induced by gut
fungal overgrowth is involved in airway inflammation via macro-
phage polarization into alternative M2 type. In vitro studies sug-
gested that Candida not only produces PGE2 in itself (Noverr
et al., 2001, 2002) but also induces PGE2 production from host
cells (Gagliardi et al., 2010; Lee et al., 2009). We showed that
Abx treatment significantly increased the PGEM levels in
Ptges/ mice (Figure 4E), suggesting that the increased PGE2
might not be derived from host cells. We also showed that the
elevated plasma PGEM was decreased by treatment with
aspirin. Cox inhibitors such as aspirin and celecoxib are able
to suppress the PGE2 synthesis by host cells. However, they
are also able to affect the biofilm formation of Candida, resulting
in the decreased PGE2 production by Candida (Alem and
Douglas, 2004). Thus, our data suggest that C. parapsilosis in
the gut, rather than in host cells, elevated the plasma PGE2st & Microbe 15, 95–102, January 15, 2014 ª2014 Elsevier Inc. 99
B C
P
G
E
M
(p
g/
m
l)
200
400
600
800
*
N.S.
500
1000
1500
P
G
E
M
(p
g/
m
l)
A chi3l3 retnlaarg1
Fo
ld
in
cr
ea
se
1
2
3
4
2
4
6
1
2
3
4* * *
DSera BAL
200
400
600
800
P
G
E
M
(p
g/
m
l)
*
N.S.
**
I
1
2
3
2
3
4
5
ol
d
in
cr
ea
se
chi3l3 retnlaarg1
2
3
4
5
* ** *
0
- +Abx
5-FC
+
- - +
0
Cp
AA
- + - +
- - + +
- + - +- +Abx
0 00
G
E
M
(p
g/
m
l)
200
300
400
500
600
700
200
300
400
500
600
700
**
**
*
**
**
**
ptges+/+ ptges-/-
E
chi3l3 retnlaarg1
2
3
4
5
1
2
3
1
2
3
ol
d
in
cr
ea
se
* ** *
N.S.N.S.
N.S.
F
0
Abx - + - +
Papain
- +
5-FC - - - - + +
J
200
400
600
100
200
300
400
500
20
40
60
al
ce
lls
(x
10
4 )
s i
no
ph
ils
(x
10
4 )
cr
op
ha
ge
s
(x
10
4 )
** ** **
0 0
1Fo
0
1
PBS
Dm-
PGE2 PBS
Dm-
PGE2PBS
Dm-
PGE2
P
G
0
100
0
100
Abx
Asp - + - +
- - + + Abx
Asp - + - +
- - + +
Asp
0
1
00
Fo
- + - +
- - + +
- + - +
- - + +
- + - +
- - + +Abx
20
30
40
50
60
200
300
400
500
600
700
100
200
300
400
500
ce
lls
(x
10
4 )
no
ph
ils
(x
10
4 )
ro
ph
ag
es
(x
10
4 )**
N.S.
**
N.S.
**
N.S.
G
0 0 0
PBS Dm-PGE2
To
ta
E
os M
ac
Papain PapainPapain
PBS Dm-PGE2
PBS Dm-PGE2
K
200
300
400
500
20
40
60
200
400
600 ** ****
al
ce
lls
(x
10
4 )
s i
no
ph
ils
(x
10
4 )
cr
op
ha
ge
s
(x
10
4 )H
20
30
40
50
200
300
400
500
200
300
400
500
600
700 *
N.S.
*
N.S.
*
N.S.
ce
lls
(x
10
4 )
op
hi
ls
(x
10
4 )
op
ha
ge
s
(x
10
4 )
0
10
0
100
0
Abx
Asp - + - +
- - + + Abx
Asp - + - +
- - + + Abx
Asp - + - +
- - + +
To
ta
l
E
os
in
M
ac
r
Papain PapainPapain
0
100
00
AMφ
Papain PapainPapain
PBS PGE2
To
ta
E
os
M
ac
Celecoxib
0
10
0
100
0
100
Papain Papain Papain
- + - +
- - + +Abx
- + - +
- - + +
- + - +
- - + +
To
ta
lc
E
os
in
M
ac
ro
PBS PGE2 PBS PGE2
Figure 4. Elevated PGE2 Levels Associated with Intestinal Fungal Overgrowth Contribute to M2 Polarization and Increase of Allergic Airway
Inflammatory Cell Infiltration
(A) Peripheral blood monocytes purified from untreated () or Abx (clindamycin + cefoperazone)-treated mice were subjected to real-time RT-PCR (n = 5).
(B)Candida parapsilosis (Cp) isolated frommouse feces was cultured or not for 48 hr in the presence or absence of 500 mMarachidonic acid (AA) and assayed for
prostaglandin E2 (PGE2) metabolite (PGEM) in the culture supernatant.
(C) Mice were left untreated or treated orally with either Abx, or Abx plus 5-FC for 2 weeks and analyzed for serum PGEM levels.
(D) Abx-treated or untreated () mice were challenged i.n. with PBS or papain every 3 days a total of five times. One day after the final challenge, mice were
analyzed for PGEM concentration in BAL fluids.
(E–G) Ptges+/+ (E–G) or Ptges/ (E) mice were left untreated or treated orally with either Abx, aspirin (Asp), or both for 2 weeks and analyzed for serum PGEM
levels (E) and expression of M2macrophagemarker genes in AMfs by real-time RT-PCR (F) (n = 5). Themice were then challenged i.n. with papain and analyzed,
as described in Figure 1 (G).
(H) Mice were left untreated or treated orally with either Abx, celecoxib, or both for 2 weeks and then challenged i.n. with papain and analyzed, as described in
Figure 1.
(I) Mice were intraperitoneally injected with dimethyl PGE2 (Dm-PGE2) or PBS every day a total of five times. One day after the final challenge, mice were analyzed
for expression of M2 macrophage marker genes in AMfs (n = 5).
(J) Mice were challenged i.n. with papain every 3 days a total of five times. The mice were also injected i.p. with dimethyl PGE2 (Dm-PGE2) or PBS 1 day before
each papain challenge a total of five times. One day after the final challenge with papain, mice were analyzed for BAL cells, as described in Figure 1.
(K) AMfs purified from naivemicewere cultured in the presence or absence of PGE2 for 24 hr and transferred i.n. to naivemice. Themicewere then challenged i.n.
with papain and analyzed for BAL cells, as described in Figure 1. Results are representative of three independent experiments. *p < 0.05; **p < 0.01. Error bars,
SD. N.S., not significant. See also Figure S4.
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Gut Dysbiosis Promotes M2 Macrophage Polarizationlevel in Abx-treated mice, which induced the polarization of
macrophage toward M2 type and then exacerbated allergic
airway inflammation.
Candida overgrowth in the intestine can be caused by exces-
sive dietary intake of sugar or carbohydrates (Vargas et al.,
1993), as well as by antibiotic treatment (Giuliano et al., 1987;
Samonis et al., 1990). In our present study, only certain antibi-
otics could promote fungal overgrowth in the gut (Figure 3A),
suggesting that specific commensal bacteria have an ability to
prevent fungal colonization. Lactobacillus can prevent coloniza-
tion of Candida through displacement of the fungi from the
epithelial layer of stomach (Savage, 1969). Furthermore, peni-
cillin treatment reduces Lactobacillus populations and promotes
fungal colonization of the gastric epithelium (Savage, 1969).
Indeed, we observed that treatment with the antibiotics
clindamycin and cefoperazone significantly reduced several
commensal bacteria, including Lactobacillus. In contrast, treat-
ment with metronidazole, which did not induce the gut fungal
overgrowth, did not affect the number of Lactobacillus (Fig-
ure S3). Further work is needed to reveal adaptation of fungi to
the host environment during antibiotic treatment. Several reports
demonstrated that patients with allergic diseases exhibited
fungal overgrowth in the intestine (Buslau et al., 1990; Pawlik
et al., 2002). Therefore, control of fungal overgrowth associated
with gut dysbiosis may be important for the treatment of, or pro-
tection against, allergic inflammatory disorders.
EXPERIMENTAL PROCEDURES
Mice
We used C57BL/6J mice derived from a colony maintained at the University of
Tsukuba Animal Research Center or, in some experiments, from Clea Japan.
Rag-1/ mice were purchased from Jackson Laboratories. Ptges ± mice on
the C57BL/6 background were kindly provided by Leslie Crofford (Vanderbilt
University). Ptges+/+ and Ptges/ mice derived from the Ptges+/ parents
were bred at the University of Michigan (Mason et al., 2013). All experiments
were performed in accordance with the guidelines of the animal ethics com-
mittee of the University of Tsukuba Animal Research Center and the University
of Michigan.
Antibiotics, Aspirin, Celecoxib, and SAP
Mice were provided with autoclaved drinking water supplemented with
clindamycin (0.5 mg/mL, Tokyo Chemical), cefoperazon (0.4 mg/mL,
Toronto Research Chemicals), ampicillin (1 mg/mL, Sigma-Aldrich), metroni-
dazole (1 mg/mL, Sigma-Aldrich), streptomycin (5 mg/mL, Wako Pure
Chemical), 5-fluorocytosine (2 mg/mL, Tokyo Chemical), aspirin (50 mg/mL,
Tokyo Chemical), or celecoxib (1 mg/mL, Tokyo Chemical). Antibiotic treatment
was started 2–4 weeks before inhalation of allergens and continued for the
duration of the experiment. Mice were intranasally treated with a drop of
SAP (100 mg in PBS per mouse, Calbiochem) solution every 3 days a total of
five times.
Papain-Induced Airway Inflammation
Every 3 days, mice were subjected to intranasal inhalation of papain (150 mg in
PBS per mouse, Wako Pure Chemical, >0.5 units/g) by placing a drop in the
nasal cavity of the mouse, a total of five challenges. BAL was performed
three times by instillation of 1ml of PBS through a tracheal cannula. Differential
cell counts were performed on cytospins stained with Wright’s stain solution
(Muto Pure Chemicals).
Fungal Numbers in Feces or Lungs
Fecal pellets or lungs were collected from individual mice, homogenized in
cold PBS, and plated at serial dilutions onto Sabouraud dextrose agar con-
taining 50 mg/ml gentamycin and 50 mg/ml chloramphenicol, and the numberCell Hosof CFUs was determined after overnight incubation at 37C. Detection limit
was 102 CFU/g feces.
Candida Inoculation
Candida species were derived from a single colony picked from Sabouraud
dextrose GC agar plate streaked with mouse or human samples. Candida
parapsilosis that we isolated from mouse feces or C. albicans, C. glabrata,
and C. tropicalis isolated from patients were grown to stationary phase
(48 hr) at 37C in Sabouraud dextrose broth with shaking. For infection of
mice, the cultures were washed and diluted to 5 3 107 CFU/mL in sterile
PBS.Mice obtained fromClea Japan orPtges+/+ andPtges/micewere inoc-
ulated with Candida (107 CFU in 200 mL) by oral gavage using mouse feeding
needles on day 1 of antibiotic treatment.
Cytokine, Chemokine, and Prostaglandin E2 Levels
Cytokine and chemokine were measured with enzyme-linked immunosorbent
assay kits (R&D Systems). Serum levels of 13,14-dihydro-15-keto PGE2
(prostaglandin E2 metabolite, PGEM) were measured with Prostaglandin E
Metabolite EIA Kit (Cayman Chemicals) in accordance with the manufacturer’s
instructions.
cDNA Synthesis and Real-Time RT-PCR
Total RNA was extracted with a Total RNA Kit I (OMEGA Bio-Tek. Inc.), and
cDNA was synthesized by using a High Capacity RNA-to-cDNA Kit (Applied
Biosystems). Real-time PCR was performed with SYBR Green master mix
(Applied Biosystems). Expression of each target gene was normalized against
that of b-actin.
PGE2 and Treatment
Dimethyl PGE2 (dm-PGE2, Calbiochem) (50 mg/mL per mouse) was given
intraperitoneally once a day for 5 days, and alveolar macrophages were
purified 1 day after final dm-PGE2 treatment for real-time RT-PCR analysis.
Dm-PGE2 (50 mg/mL in PBS per mouse) was also given intraperitoneally
1 day before each papain treatment every 3 days a total of five challenges.
For adoptive transfer, alveolar macrophages purified from naive mice were
incubated with PGE2 (50 ng/mL, Tokyo Chemical) for 24 hr.
Adoptive Transfer of Macrophages
Alveolar macrophages were obtained from naive or antibiotic-treated mice
after BAL with PBS. BBMs, generated as described (Celada et al., 1984),
were cultured for 24 hr in the presence of either IFN-g (20 ng/mL) or IL-4
(10 ng/mL), IL-13 (10 ng/mL), and IL-10 (20 ng/mL; all from R&D Systems)
for differentiation into M1 or M2 macrophages, respectively. Macrophages
(23 105 cells) were transferred intranasally into naive mice 8 hr before the first
papain inhalation.
Statistical Analysis
Statistical significance between groups was determined by Mann-Whitney
test. In vivo and in vitro mRNA expression was analyzed with two-tailed
t test with unequal variance (Aspin-Welch’s t test). Differences were consid-
ered significant when p values were <0.05.
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